Microchip Technology, Inc. v. Aptiv Services US, LLC

CourtDistrict Court, D. Delaware
DecidedJuly 15, 2024
Docket1:23-cv-00778
StatusUnknown

This text of Microchip Technology, Inc. v. Aptiv Services US, LLC (Microchip Technology, Inc. v. Aptiv Services US, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Microchip Technology, Inc. v. Aptiv Services US, LLC, (D. Del. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

MICROCHIP TECHNOLOGY, INC.

v. Case No. 1:23-cv-00778-JDW

APTIV SERVICES US, LLC,

MEMORANDUM

Microchip Technology, Inc. sued Aptiv Services US, LLC alleging that Aptiv infringes three of Microchip‘s patents. The Parties have presented disputes over the meaning of four disputed claim terms stemming from two patents: (1) U.S. Patent No. 7,564,665 (‘665 Patent); (2) U.S. Patent No. 9,471,074 (‘074 Patent). I held a hearing on June 21, 2024, and now resolve the disputed constructions. I. LEGAL STANDARD A. General Principles Of Claim Construction “It is a bedrock principle of patent law that the claims of a patent define the invention to which the patentee is entitled the right to exclude.” , 415 F.3d 1303, 1312 (Fed. Cir. 2005) (quote omitted). Claim construction is a matter of law. , 574 U.S. 318, 325 (2015). “[T]here is no magic formula or catechism” for construing a patent claim, nor is a court “barred from considering any particular sources or required to analyze sources in any specific sequence[.]” , 415 F. 3d at 1324. Instead, a court is free to attach the appropriate weight to appropriate sources “in light of the statutes and policies that inform patent

law.” (citation omitted). A court generally gives the words of a claim “their ordinary and customary meaning,” which is the “meaning the term would have to a person of ordinary skill in the

art at the time of the invention, i.e., as of the effective filing date of the patent application.” at 1312-13 (quotations omitted). Usually, a court first considers the claim language; then the remaining intrinsic evidence; and finally, the extrinsic evidence in limited circumstances. , 256 F.3d

1323, 1331-32 (Fed. Cir. 2001). While “the claims themselves provide substantial guidance as to the meaning of particular claim terms[,]” a court also must consider the context of the surrounding words. , 415 F. 3d at 1314. In addition, the patent specification “is always highly relevant to the claim construction analysis and indeed is

often the single best guide to the meaning of a disputed term.” , 19 F.4th 1325, 1330 (Fed. Cir. 2021) (quotation omitted). But, while a court must construe claims to be consistent with the specification, it must “avoid the

danger of reading limitations from the specification into the claim . . . .” , 415 F.3d at 1323. This is a “fine” distinction. , 156 F.3d 1182, 1186-87 (Fed. Cir. 1998). In addition, “even when the specification describes only a single embodiment, the claims of the patent will not be read restrictively unless the patentee has demonstrated a clear intention to limit the claim scope using ‘words or expressions of manifest exclusion or restriction.’” , 755

F.3d 1367, 1372 (Fed. Cir. 2014) (quotation omitted) (cleaned up). A court may refer to extrinsic evidence only if the disputed term’s ordinary and accustomed meaning cannot be discerned from the intrinsic evidence.

, 90 F.3d 1576, 1584 (Fed. Cir. 1996). Although a court may not use extrinsic evidence to vary or contradict the claim language, extrinsic materials “may be helpful to explain scientific principles, the meaning of technical terms, and terms of art that appear in the patent and prosecution history.”

, 52 F.3d 967, 980 (Fed. Cir. 1995). Extrinsic evidence is used “to ensure that the court’s understanding of the technical aspects of the patent is consistent with that of a person of skill in the art[.]” , 415 F.3d at 1318. The Federal Circuit has cautioned against relying upon expert reports and testimony that is generated for the

purpose of litigation because of the likelihood of bias. ; , 509 U.S. 579, 595 (1993) (“Expert evidence can be both powerful and quite misleading because of the difficulty in evaluating it.”) (quotation omitted).

B. Construction Of Means-Plus-Function Limitations When construing claim terms, a court must consider whether they are “means- plus-function” limitations. 35 U.S.C. § 112(f) governs the interpretation of means-plus- function claim terms: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. 35 U.S.C. § 112(f). For patents that predate the America Invents Act, the same standard applies under 35 U.S.C § 112, ¶ 6. To determine whether Section 112, ¶ 6 governs a claim, the “essential inquiry” is “whether the words of the claim are understood by persons of ordinary skill in the art to have a sufficiently definite meaning as the name for structure.” , 792 F.3d 1339, 1348 (Fed. Cir. 2015) (en banc).1 If a claim term does not use the word “means,” there is a rebuttable presumption that means-plus-function claiming

under Section 112, ¶ 6 does not apply. at 1349. To rebut it, a challenger must demonstrate that a claim term either fails to “recite sufficiently definite structures” or recites “function without reciting sufficient structure for performing that function.”

“The ultimate question is whether the claim language, read in light of the specification, recites sufficiently definite structure to avoid [Section] 112, ¶ 6.” , 933 F.3d 1336, 1341 (Fed. Cir. 2019) (quote omitted). Courts use a two-step process to construe means-plus-function limitations. First,

the court must determine the claimed function. , 208 F.3d 1352, 1361 (Fed. Cir. 2000). Second, the court must identify the

1 An Federal Circuit joined the potion of the decision discussing the applicability of Section 112. , 892 F.3d at 1347-49 & n.3. corresponding structure that the specification discloses to perform that function. When the specification discloses “distinct and alternative structures for performing the

claimed function,” the proper construction should embrace each one. , 305 F.3d 1337, 1346 (Fed. Cir. 2002). The structure disclosed in the patent specification that corresponds to the claimed function limits the scope of a means-plus-

function claim. , 344 F.3d 1205, 1219 (Fed. Cir. 2003). C. Indefiniteness “Indefiniteness is a matter of claim construction, and the same principles that

generally govern claim construction are applicable to determining whether allegedly indefinite claim language is subject to construction.” , No. CV 17-313, 2020 WL 3403207, at *5 (D. Del. June 19, 2020) (internal quotations omitted). “The internal coherence and context assessment of the patent, and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Comark Communications, Inc. v. Harris Corporation
156 F.3d 1182 (Federal Circuit, 1998)
Creo Products, Inc. v. Presstek, Inc., Defendant-Cross
305 F.3d 1337 (Federal Circuit, 2002)
Home Diagnostics, Inc. v. Lifescan, Inc.
381 F.3d 1352 (Federal Circuit, 2004)
The Gillette Company v. Energizer Holdings, Inc.
405 F.3d 1367 (Federal Circuit, 2005)
Halliburton Energy Services, Inc. v. M-I LLC
514 F.3d 1244 (Federal Circuit, 2008)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Hill-Rom Services, Inc. v. Stryker Corporation
755 F.3d 1367 (Federal Circuit, 2014)
Richard Williamson v. Citrix Online, LLC
792 F.3d 1339 (Federal Circuit, 2015)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
789 F.3d 1335 (Federal Circuit, 2015)
Basf Corporation v. Johnson Matthey Inc.
875 F.3d 1360 (Federal Circuit, 2017)
Berkheimer v. Hp Inc.
881 F.3d 1360 (Federal Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Microchip Technology, Inc. v. Aptiv Services US, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/microchip-technology-inc-v-aptiv-services-us-llc-ded-2024.